Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140M Buy
1,053,896
+672,614
+176% +$76.1M 0.01% 764
2026
Q1
$42.5M Sell
381,282
-373,554
-49% -$44.2M ﹤0.01% 1417
2025
Q4
$102M Buy
754,836
+720,222
+2,081% +$78.6M 0.01% 874
2025
Q3
$2.94M Buy
+34,614
New +$2.12M ﹤0.01% 5008

Other funds holding ABVX

Jeff Yass's ABVX Position: Q2 2026 in Review

Jeff Yass increased its Abivax (ABVX) stake by 176% in Q2 2026, buying an estimated $76.1M and bringing the position to 1,053,896 shares worth $140M. The position accounts for 0.01% of the portfolio, ranked #764.

Jeff Yass first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Jeff Yass held 1,053,896 shares of Abivax worth $140M as of Q2 2026.
  • Jeff Yass bought 672,614 Abivax shares in Q2 2026, an estimated $76.1M.
  • Abivax made up 0.01% of Jeff Yass's portfolio in Q2 2026, its #764 holding.
  • Jeff Yass first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.